Posted by Michael Wonder on 04 Jul 2024
Zilucoplan for the treatment of patients with generalised antibody positive myasthenia gravis
4 July 2024 - The Department of Health and Social Care has asked the NICE to produce guidance on the use of zilucoplan sodium in the NHS in England.
For the time being, zilucoplan sodium is not recommended as an add-on to standard treatment for adults with generalised anti-acetylcholine receptor antibody positive myasthenia gravis.
